Comorbidities associated with leptin and psoriasis

Journal of Drugs in Dermatology

Volumn 12, Issue 5, 2013, Pages 515-

  Kapoor, Shailendra ^a  

^a Private Practice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ARTHRITIS; ATHEROSCLEROSIS; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE COURSE; GENETIC POLYMORPHISM; HUMAN; LETTER; OBESITY; PROTEIN BLOOD LEVEL; PSORIASIS; PSORIATIC ARTHRITIS; RISK FACTOR; WEIGHT REDUCTION;

FEMALE; HUMANS; LEPTIN; MALE; PSORIASIS;

EID: 84877630371     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Aly DG, Abdallah IY, Hanafy NS, Elsaie ML, Hafiz NA. Elevated serum leptin levels in nonobese patients with psoriasis. J Drugs Dermatol. 2013;12(2):e25-e29.
2. Abdel Hay RM, Rashed LA. Association between the leptin gene 2548G/A polymorphism, the plasma leptin and the metabolic syndrome with psoriasis. Exp Dermatol. 2011;20(9):715-719.
3. Enany B, El Zohiery AK, Elhilaly R, Badr T. Carotid intima-media thickness and serum leptin in psoriasis. Herz. 2012;37(5):527-533.
4. Russolillo A, Iervolino S, Peluso R, et al. Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management. Rheumatology (Oxford). 2013;52(1):62-67.
5. Xue Y, Jiang L, Cheng Q, et al. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. PLoS One. 2012;7(10):e46740.